| molecular function |
|---|
| | GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
| | GO:0031625 | | ubiquitin protein ligase binding | | Interacting selectively and non-covalently with a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| biological process |
|---|
| | GO:0006919 | | activation of cysteine-type endopeptidase activity involved in apoptotic process | | Any process that initiates the activity of the inactive enzyme cysteine-type endopeptidase in the context of an apoptotic process. |
| | GO:0008637 | | apoptotic mitochondrial changes | | The morphological and physiological alterations undergone by mitochondria during apoptosis. |
| | GO:0006915 | | apoptotic process | | A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died. |
| | GO:0007420 | | brain development | | The process whose specific outcome is the progression of the brain over time, from its formation to the mature structure. Brain development begins with patterning events in the neural tube and ends with the mature structure that is the center of thought and emotion. The brain is responsible for the coordination and control of bodily activities and the interpretation of information from the senses (sight, hearing, smell, etc.). |
| | GO:0090150 | | establishment of protein localization to membrane | | The directed movement of a protein to a specific location in a membrane. |
| | GO:0097191 | | extrinsic apoptotic signaling pathway | | A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with either a ligand binding to a cell surface receptor, or a ligand being withdrawn from a cell surface receptor (e.g. in the case of signaling by dependence receptors), and ends when the execution phase of apoptosis is triggered. |
| | GO:0034349 | | glial cell apoptotic process | | Any apoptotic process in a glial cell, a non-neuronal cell of the nervous system. |
| | GO:0097284 | | hepatocyte apoptotic process | | Any apoptotic process in a hepatocyte, the main structural component of the liver. |
| | GO:0097345 | | mitochondrial outer membrane permeabilization | | The process by which the mitochondrial outer membrane becomes permeable to the passing of proteins and other molecules from the intermembrane space to the cytosol as part of the apoptotic signaling pathway. |
| | GO:0043065 | | positive regulation of apoptotic process | | Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process. |
| | GO:2001238 | | positive regulation of extrinsic apoptotic signaling pathway | | Any process that activates or increases the frequency, rate or extent of extrinsic apoptotic signaling pathway. |
| | GO:0032464 | | positive regulation of protein homooligomerization | | Any process that activates or increases the frequency, rate or extent of protein homooligomerization. |
| | GO:0032461 | | positive regulation of protein oligomerization | | Any process that activates or increases the frequency, rate or extent of protein oligomerization. |
| | GO:0090200 | | positive regulation of release of cytochrome c from mitochondria | | Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation. |
| | GO:0051260 | | protein homooligomerization | | The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer. |
| | GO:0006626 | | protein targeting to mitochondrion | | The process of directing proteins towards and into the mitochondrion, usually mediated by mitochondrial proteins that recognize signals contained within the imported protein. |
| | GO:2000045 | | regulation of G1/S transition of mitotic cell cycle | | Any cell cycle regulatory process that controls the commitment of a cell from G1 to S phase of the mitotic cell cycle. |
| | GO:0042981 | | regulation of apoptotic process | | Any process that modulates the occurrence or rate of cell death by apoptotic process. |
| | GO:0042127 | | regulation of cell proliferation | | Any process that modulates the frequency, rate or extent of cell proliferation. |
| | GO:1902108 | | regulation of mitochondrial membrane permeability involved in apoptotic process | | Any regulation of mitochondrial membrane permeability that is involved in apoptotic process. |
| | GO:0032459 | | regulation of protein oligomerization | | Any process that modulates the frequency, rate or extent of protein oligomerization. |
| | GO:0001836 | | release of cytochrome c from mitochondria | | The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation. |
| | GO:0032355 | | response to estradiol | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of stimulus by estradiol, a C18 steroid hormone hydroxylated at C3 and C17 that acts as a potent estrogen. |
| | GO:0042770 | | signal transduction in response to DNA damage | | A cascade of processes induced by the detection of DNA damage within a cell. |
| cellular component |
|---|
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0005829 | | cytosol | | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| | GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| | GO:0032592 | | integral component of mitochondrial membrane | | The component of the mitochondrial membrane consisting of the gene products having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane. |
| | GO:0016020 | | membrane | | A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it. |
| | GO:0031966 | | mitochondrial membrane | | Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope. |
| | GO:0005739 | | mitochondrion | | A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration. |
Description
